Brief: Cognition Therapeutics Announces Pricing Of Public Offering
10/11/2022 13:13
Nov 10 (Reuters) - Cognition Therapeutics Inc CGTX.O :
* COGNITION THERAPEUTICS ANNOUNCES PRICING OF PUBLIC
OFFERING
* COGNITION THERAPEUTICS ANNOUNCES PRICING OF PUBLIC
OFFERING
* COGNITION THERAPEUTICS INC - PRICING OF PUBLIC OFFERING OF
5
MILLION SHARES OF ITS COMMON STOCK, AT A PUBLIC OFFERING PRICE
OF $1.20 PER SHARE
Source text for Eikon: ID:nGNX6bVZ8q
Further company coverage: CGTX.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Cognition Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Quest Diagnostics, Tractor Supply, Dutch Bros
U.S. STOCKS ON THE MOVE-CME, Lockheed Martin, Valero Energy
Cognition rises after FDA backs late-stage trial plan for dementia drug
Brief: Cognition Therapeutics Announces Issuance Of Composition Of Matter Patent, Extending Protection For Zervimesine (CT1812) Through 2045
Brief: Cognition Therapeutics Schedules A Type C Meeting With FDA To Align On Endpoints For Phase 3 Trial Of Zervimesine (Ct1812) In DLB